Article
Selection of regimens for patients with hepatitis C virus genotype/serotype discrepancy.
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology - 1 Jan 2017
Katsushima Shinji, Kobata Tatsuro, Komeda Toshiki, Hamada Seiko, Chikugo Kouki, Nakano Shigeharu, Shimogama Tsubasa, Kumagai Ken, Ohta Yoshiyuki, Endoh Bunji, Esaka Naoki, Iwamoto Satoru, Kasahara Katsuhiro, Shima Nobuko, Mizumoto Yoshinori
Abstract excerpt
In the present study, the usefulness of the resistance-associated variant (RAV) analysis to select direct acting antiviral (DAA) drugs for patients with hepatitis C virus (HCV) genotype/serotype discrepancy was evaluated. The core-genotype and serotype were determined in the 559 patients recruited in the study. The RAV analysis and NS5B-genotype determination were performed in the eight patients who exhibited a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.